Met acts through Abl to regulate p53 transcriptional outcomes and cell survival in the developing liver.

[1]  M. Genestine,et al.  Pool-Specific Regulation of Motor Neuron Survival by Neurotrophic Support , 2011, The Journal of Neuroscience.

[2]  J. Arthur,et al.  Genetic analysis of specific and redundant roles for p38α and p38β MAPKs during mouse development , 2011, Proceedings of the National Academy of Sciences.

[3]  Chi Wang,et al.  c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression , 2011, Oncogene.

[4]  Thomas J. Ostendorf,et al.  Hepatocyte growth factor protects retinal ganglion cells by increasing neuronal survival and axonal regeneration in vitro and in vivo , 2011, Journal of neurochemistry.

[5]  A. Furlan,et al.  Abl interconnects oncogenic Met and p53 core pathways in cancer cells , 2011, Cell Death and Differentiation.

[6]  B. Pettmann,et al.  Enhanced neuronal Met signalling levels in ALS mice delay disease onset , 2011, Cell Death and Disease.

[7]  Seung-Moo Noh,et al.  Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice. , 2010, The Journal of clinical investigation.

[8]  L. Trusolino,et al.  MET signalling: principles and functions in development, organ regeneration and cancer , 2010, Nature Reviews Molecular Cell Biology.

[9]  S. Goff,et al.  Abl Family Tyrosine Kinases Are Essential for Basement Membrane Integrity and Cortical Lamination in the Cerebellum , 2010, The Journal of Neuroscience.

[10]  D. Meek,et al.  Phosphorylation of serine 392 in p53 is a common and integral event during p53 induction by diverse stimuli. , 2010, Cellular signalling.

[11]  S. Goff,et al.  c-Abl tyrosine kinase regulates cardiac growth and development , 2009, Proceedings of the National Academy of Sciences.

[12]  Scott W. Lowe,et al.  Stem cells: The promises and perils of p53 , 2009, Nature.

[13]  A. Sirvent,et al.  Cytoplasmic signalling by the c‐Abl tyrosine kinase in normal and cancer cells , 2008, Biology of the cell.

[14]  Eduardo Sontag,et al.  Transcriptional control of human p53-regulated genes , 2008, Nature Reviews Molecular Cell Biology.

[15]  D. Srinivasan,et al.  Aggressive breast cancer cells are dependent on activated Abl kinases for proliferation, anchorage-independent growth and survival , 2008, Oncogene.

[16]  G. V. Vande Woude,et al.  Showering c-MET-dependent cancers with drugs. , 2008, Current opinion in genetics & development.

[17]  Susan J Fisher,et al.  Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. , 2008, Molecular cell.

[18]  J. Pennings,et al.  The Absence of Ser389 Phosphorylation in p53 Affects the Basal Gene Expression Level of Many p53-Dependent Genes and Alters the Biphasic Response to UV Exposure in Mouse Embryonic Fibroblasts , 2008, Molecular and Cellular Biology.

[19]  J. Comella,et al.  Met signals hepatocyte survival by preventing Fas‐triggered FLIP degradation in a PI3k‐Akt–dependent manner , 2007, Hepatology.

[20]  A. Porras,et al.  Met acts on Mdm2 via mTOR to signal cell survival during development , 2007, Development.

[21]  Karen H. Vousden,et al.  p53 in health and disease , 2007, Nature Reviews Molecular Cell Biology.

[22]  D. Srinivasan,et al.  Activation of Abl tyrosine kinases promotes invasion of aggressive breast cancer cells. , 2006, Cancer research.

[23]  M. Matsumoto,et al.  Posttranslational phosphorylation of mutant p53 protein in tumor development , 2006, Medical Molecular Morphology.

[24]  F. Maina,et al.  Combined Signaling through ERK, PI3K/AKT, and RAC1/p38 Is Required for Met-triggered Cortical Neuron Migration*♦ , 2006, Journal of Biological Chemistry.

[25]  Y. Haupt,et al.  C-Abl as a modulator of p53. , 2005, Biochemical and biophysical research communications.

[26]  Carmen Birchmeier,et al.  Met provides essential signals for liver regeneration. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Thorgeirsson,et al.  Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. Arber,et al.  Met Signaling Is Required for Recruitment of Motor Neurons to PEA3-Positive Motor Pools , 2003, Neuron.

[29]  Tony Hunter,et al.  Regulation of F-actin-dependent processes by the Abl family of tyrosine kinases , 2003, Journal of Cell Science.

[30]  W. Snider,et al.  Signaling the Pathway to Regeneration , 2002, Neuron.

[31]  M. Oren,et al.  Requirement for Mdm2 in the survival effects of Bcr-Abl and interleukin 3 in hematopoietic cells. , 2001, Cancer research.

[32]  A. Davies,et al.  Coupling Met to specific pathways results in distinct developmental outcomes. , 2001, Molecular cell.

[33]  J. Schlessinger,et al.  Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.

[34]  I. Schieren,et al.  Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation , 2000, Nature Genetics.

[35]  A. Kazlauskas,et al.  c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. , 1999, Genes & development.

[36]  D. Baltimore,et al.  Essential Roles for the Abl and Arg Tyrosine Kinases in Neurulation , 1998, Neuron.

[37]  A. Davies,et al.  Multiple Roles for Hepatocyte Growth Factor in Sympathetic Neuron Development , 1998, Neuron.

[38]  A. Davies,et al.  Met receptor signaling is required for sensory nerve development and HGF promotes axonal growth and survival of sensory neurons. , 1997, Genes & development.

[39]  A. Simeone,et al.  Uncoupling of Grb2 from the Met Receptor In Vivo Reveals Complex Roles in Muscle Development , 1996, Cell.

[40]  A. Mccarthy.  Development , 1996, Current Opinion in Neurobiology.

[41]  S. Goff,et al.  Mice homozygous for the abl m1 mutation show poor viability and depletion of selected B and T cell populations , 1991, Cell.

[42]  R. Bronson,et al.  Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene , 1991, Cell.

[43]  J. Schlessinger,et al.  Signaling by Receptor Tyrosine Kinases , 1993 .